Welcome to our dedicated page for Gaxos.ai news (Ticker: GXAI), a resource for investors and traders seeking the latest updates and insights on Gaxos.ai stock.
Gaxos.AI Inc. (GXAI) is at the forefront of the artificial intelligence revolution, transforming the way humans engage with technology. The company focuses on developing innovative applications that enhance mental and physical well-being, offering solutions in coaching and gaming sectors. Driven by a commitment to address modern-day challenges, Gaxos.AI aims to improve healthier and longer living through the integration of empathetic and advanced AI technologies. Their human-centered solutions are designed to resonate with everyday users, promoting a balanced and enriched life.
Recent Achievements:
- Introducing Gaxos.AI: Recently unveiled, this initiative marks a significant step in AI-based wellness applications, promising groundbreaking advancements in the field.
- Collaborative Efforts: Gaxos.AI has formed strategic partnerships to enhance its technological offerings and reach a broader audience.
- Research and Development: The company is continuously investing in R&D to stay ahead in the competitive AI landscape, focusing on empathetic AI solutions that cater to user needs.
Financial Health: Gaxos.AI is financially robust, with sound strategies in place to ensure sustained growth and innovation. Their dedication to leveraging AI for meaningful impact has garnered investor confidence, reflected in their stable stock performance.
Contact Information:
- Investor Relations: E: ir@gaxos.ai T: 1-888-319-2499
Rhea-AI Summary
Gaxos Health, a subsidiary of Gaxos.ai Inc., has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. Dr. Margolis brings over 25 years of experience in urology, focusing on men's health and regenerative therapies. Dr. Pavell specializes in physical medicine and rehabilitation, offering advanced non-operative treatments. The addition of these top medical talents demonstrates Gaxos Health's commitment to providing innovative solutions and creating value for shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6%
Tags
-
Rhea-AI Summary
Gaxos.ai Inc. (NASDAQ: GXAI) has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) for continued listing on the NASDAQ Capital Market. The Company's common stock traded above $1.00 for 10 consecutive days as of March 21, 2024, resolving the non-compliance issue.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.39%
Tags
-
Rhea-AI Summary
Gaxos.ai Inc. (GXAI) closed a private placement offering, selling 628,367 shares of common stock, series A warrants, and short-term series B warrants at $5.57 per share. The gross proceeds were $3.5 million. H.C. Wainwright & Co. acted as the exclusive placement agent. The company plans to use the net proceeds for working capital and general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.59%
Tags
Rhea-AI Summary
Gaxos.ai Inc. (NASDAQ: GXAI) announced a private placement of common stock and warrants, totaling 628,367 shares, at a purchase price of $5.57 per share. The series A and short-term series B warrants have exercise prices of $5.50 per share and expire at different intervals. The private placement is set to close soon.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
51.13%
Tags
-
Rhea-AI Summary
Gaxos.ai Inc. acquires AI technology from Ultiself to enhance Gaxos Health's offerings, aiming to provide customized solutions in the health and wellness industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
51.13%
Tags
-
News
Rhea-AI Summary
Gaxos.ai Inc. (NASDAQ: GXAI) announces a 1-for-12 reverse stock split effective March 7, 2024, consolidating every 12 shares into 1 share. The Company's common stock will trade on a post-split basis under the same symbol 'GXAI' on The Nasdaq Capital Market. The reverse split aims to streamline the share structure, with approximately 981,523 shares outstanding post-split.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.98%
Tags
Rhea-AI Summary
Gaxos.ai Inc. announces the formation of a medical advisory board within its health and wellness division, Gaxos Health, led by Dr. Nate Lebowitz, M.D. The board aims to provide expertise in product development and strategic opportunities for creating shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.29%
Tags
-
Rhea-AI Summary
Gaxos.ai Inc. announces the launch of an artificial intelligence solution for game developers through Gaxos Gaming, aiming to revolutionize game development with AI-powered creativity, seamless integration, dynamic content generation, and customized solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
177.25%
Tags
-
News
Rhea-AI Summary
Gaxos.ai Inc. announces a strategic expansion with a dual-division structure, Gaxos Gaming and Gaxos Health, focusing on AI applications in gaming and health sectors. Gaxos Health aims to revolutionize personal health and wellness through AI-powered health optimization solutions, personalized wellness strategies, and data-driven health plans. The company also launched four games in 2023, with plans for more in 2024, and has successfully repurchased and cancelled 244,184 shares of its common stock under a share buyback program. Additionally, the company has changed its name to Gaxos.ai Inc. and is now trading under the ticker symbol GXAI on the Nasdaq Capital Market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.62%
Tags
Rhea-AI Summary
Gaxos.AI (Gaxos) unveils a revolutionary initiative to enhance mental and physical health, combat loneliness, and promote longevity through a suite of artificial intelligence applications. Leveraging cutting-edge AI, Gaxos.AI aims to offer meaningful support in mental and physical health, companionship, coaching, and tailored guidance for improving overall wellbeing. CEO Vadim Mats emphasizes the expansion into mental health and companionship, aligning with the long-term vision of creating solutions that deeply resonate with people globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.33%
Tags
FAQ
What is the current stock price of Gaxos.ai (GXAI)?
The current stock price of Gaxos.ai (GXAI) is $1.76 as of November 14, 2024.
What is the market cap of Gaxos.ai (GXAI)?
The market cap of Gaxos.ai (GXAI) is approximately 3.4M.
What is Gaxos.AI Inc.?
Gaxos.AI Inc. is a company specializing in artificial intelligence applications aimed at improving mental and physical well-being through coaching and gaming solutions.
What sectors does Gaxos.AI operate in?
Gaxos.AI operates primarily in the wellness, coaching, and gaming sectors, developing AI applications that promote healthier and longer living.
What recent achievements has Gaxos.AI made?
Gaxos.AI has recently introduced new AI wellness applications, formed strategic partnerships, and continues to invest in research and development to advance empathetic AI technologies.
How is Gaxos.AI contributing to healthier living?
Gaxos.AI develops human-centered AI technologies that focus on mental and physical well-being, offering practical solutions for a balanced lifestyle.
What is the financial condition of Gaxos.AI?
Gaxos.AI is financially stable with strong growth strategies and solid investor confidence, reflected in its consistent stock performance.
How can I contact Gaxos.AI's investor relations?
You can reach Gaxos.AI's investor relations via email at ir@gaxos.ai or by phone at 1-888-319-2499.
What makes Gaxos.AI's AI solutions unique?
Gaxos.AI's solutions are unique due to their empathetic AI technologies, which are designed to be intuitive and user-friendly, addressing real-world wellness challenges effectively.
What are Gaxos.AI's core values?
Gaxos.AI values innovation, empathy, and the pursuit of enhancing human well-being through cutting-edge AI technologies.
Where can I find more information about Gaxos.AI's latest projects?
You can find the latest information about Gaxos.AI's projects and updates on their official website and through their investor relations contact.
Is Gaxos.AI involved in any partnerships?
Yes, Gaxos.AI has formed strategic partnerships to enhance its technological capabilities and extend its reach in the AI and wellness markets.
Gaxos.ai Inc.
Nasdaq:GXAI
GXAI Rankings
GXAI Stock Data
3.43M
1.89M
11.94%
5.63%
2.07%
Electronic Gaming & Multimedia
Services-prepackaged Software
United States of America
ROSELAND